Immediate Impact
1 from Science/Nature 44 standout
Citing Papers
Radiopharmaceuticals and their applications in medicine
2025 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Works of A H E Herbers being referenced
Rituximab‐PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT : results from a phase II HOVON study
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A H E Herbers | 206 | 196 | 80 | 17 | 415 | |
| Dennis A. Casciato | 70 | 52 | 117 | 19 | 482 | |
| Chiaki Arai | 142 | 66 | 24 | 28 | 482 | |
| M. Viot | 201 | 184 | 6 | 20 | 458 | |
| E Blum | 68 | 93 | 64 | 30 | 460 | |
| Edward E. Morse | 129 | 54 | 158 | 16 | 377 | |
| Graw Rg | 266 | 88 | 87 | 12 | 434 | |
| Benedito A. Carneiro‐Filho | 59 | 88 | 12 | 12 | 457 | |
| Hugh M. Clink | 144 | 56 | 104 | 23 | 435 | |
| S. C. Schimpff | 179 | 58 | 37 | 18 | 493 | |
| Anca Zalmanovici Trestioreanu | 101 | 55 | 5 | 12 | 497 |
All Works
Login with ORCID to disown or claim papers
Loading papers...